Colorectal Cancer New Indication: Pembrolizumab for MSI-High Colorectal Cancer Ulas D. Bayraktar, MD 2022-07-16
Prostate Cancer New Indication: Darolutamide in Metastatic Hormone-Sensitive Prostate Cancer Ulas D. Bayraktar, MD 2022-05-20
Acute myeloid leukemia New Protocol: Ivosidenib and Azacitidine in IDH1-Mutated AML Ulas D. Bayraktar, MD 2022-05-20
Soft Tissue Sarcoma New Indication: Selinexor for Advanced Dedifferentiated Liposarcoma Ulas D. Bayraktar, MD 2022-05-20
Nervous System Tumor New Indication: Dabrafenib and Trametinib in bRAF V600E Mutant Glioma Ulas D. Bayraktar, MD 2022-03-16
Non-Small Cell Lung Cancer New Indication: Trastuzumab Deruxtecan for her2-Mutant NSCLC Ulas D. Bayraktar, MD 2022-03-16
